Xenon Pharmaceuticals Inc (NAS:XENE)
$ 43.33 1.62 (3.88%) Market Cap: 3.28 Bil Enterprise Value: 2.45 Bil PE Ratio: 0 PB Ratio: 3.88 GF Score: 41/100

Xenon Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 03:30PM GMT
Release Date Price: $36.94 (-3.45%)
Tessa Thomas Romero
JPMorgan Chase & Co, Research Division - Associate

Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Tessa Romero. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Taylor Hanley and Adhiraj Chauhan from the team. We are pleased to welcome Xenon Pharmaceuticals to kick off our first day of the conference. And speaking on behalf of the company, we have CEO, Ian Mortimer. Before I turn it over to Ian, I just wanted to highlight the Q&A. There is a -- there will be a Q&A coming up here. There is an Ask A Question for those folks listening on the webcast, and I'm happy to ask the question on your behalf.

So with that, Ian, over to you.

Ian C. Mortimer
Xenon Pharmaceuticals Inc. - President, CEO & Director

Thanks, Tess, and good morning, everyone. Great to be here and great to kick off JPMorgan, first thing on a Monday morning. Tremendous amount of progress at Xenon over the last 12 months, so we'll review some of that, and then we'll also review the milestones going

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot